Dan Leonard
Stock Analyst at UBS
(3.93)
# 638
Out of 5,022 analysts
301
Total ratings
55.95%
Success rate
8.78%
Average return
Main Sectors:
Stocks Rated by Dan Leonard
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| A Agilent Technologies | Upgrades: Buy | $130 → $170 | $138.04 | +23.15% | 22 | Oct 8, 2025 | |
| GH Guardant Health | Maintains: Buy | $70 → $80 | $62.56 | +27.88% | 10 | Sep 25, 2025 | |
| TXG 10x Genomics | Maintains: Neutral | $12 → $13 | $11.54 | +12.65% | 6 | Aug 8, 2025 | |
| EXAS Exact Sciences | Maintains: Neutral | $61 → $53 | $60.56 | -12.48% | 10 | Aug 7, 2025 | |
| CERT Certara | Maintains: Buy | $18 → $15 | $11.90 | +26.05% | 10 | Aug 7, 2025 | |
| MEDP Medpace Holdings | Downgrades: Sell | $300 → $305 | $516.93 | -41.00% | 2 | Jul 29, 2025 | |
| TMO Thermo Fisher Scientific | Maintains: Neutral | $460 → $500 | $525.83 | -4.91% | 17 | Jul 24, 2025 | |
| DHR Danaher | Maintains: Buy | $240 → $225 | $206.15 | +9.14% | 18 | Jul 23, 2025 | |
| IQV IQVIA Holdings | Maintains: Buy | $185 → $225 | $204.76 | +9.88% | 16 | Jul 23, 2025 | |
| MTD Mettler-Toledo International | Upgrades: Buy | $1,530 → $1,350 | $1,303.04 | +3.60% | 9 | May 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $95 → $70 | $59.27 | +18.10% | 11 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $57 → $45 | $36.52 | +23.22% | 11 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $355 → $310 | $305.05 | +1.62% | 20 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $355 → $310 | $307.90 | +0.68% | 20 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $145 → $115 | $91.14 | +26.18% | 2 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $122 → $99 | $89.67 | +10.40% | 1 | Apr 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $29 → $25 | $13.91 | +79.73% | 7 | Jan 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $250 → $185 | $170.13 | +8.74% | 6 | Jan 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $7 → $9 | $9.32 | -3.43% | 2 | Oct 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $35 | $22.39 | +56.32% | 4 | Dec 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $225 → $200 | $91.00 | +119.78% | 16 | Aug 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $14 → $11 | $3.23 | +240.56% | 6 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $70 | $172.81 | -59.49% | 7 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Underperform | $7 | $15.58 | -55.07% | 2 | Feb 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $345 | $333.14 | +3.56% | 12 | Aug 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $260 | $185.91 | +39.85% | 5 | Aug 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $160 → $145 | $185.39 | -21.79% | 10 | Feb 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $95 → $90 | $65.92 | +36.53% | 12 | Feb 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $62 → $64 | $47.50 | +34.00% | 3 | Dec 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $330 → $340 | $279.78 | +21.52% | 11 | Dec 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $24 | $24.12 | -0.50% | 1 | Aug 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $45 → $35 | $7.80 | +348.72% | 12 | Aug 14, 2019 |
Agilent Technologies
Oct 8, 2025
Upgrades: Buy
Price Target: $130 → $170
Current: $138.04
Upside: +23.15%
Guardant Health
Sep 25, 2025
Maintains: Buy
Price Target: $70 → $80
Current: $62.56
Upside: +27.88%
10x Genomics
Aug 8, 2025
Maintains: Neutral
Price Target: $12 → $13
Current: $11.54
Upside: +12.65%
Exact Sciences
Aug 7, 2025
Maintains: Neutral
Price Target: $61 → $53
Current: $60.56
Upside: -12.48%
Certara
Aug 7, 2025
Maintains: Buy
Price Target: $18 → $15
Current: $11.90
Upside: +26.05%
Medpace Holdings
Jul 29, 2025
Downgrades: Sell
Price Target: $300 → $305
Current: $516.93
Upside: -41.00%
Thermo Fisher Scientific
Jul 24, 2025
Maintains: Neutral
Price Target: $460 → $500
Current: $525.83
Upside: -4.91%
Danaher
Jul 23, 2025
Maintains: Buy
Price Target: $240 → $225
Current: $206.15
Upside: +9.14%
IQVIA Holdings
Jul 23, 2025
Maintains: Buy
Price Target: $185 → $225
Current: $204.76
Upside: +9.88%
Mettler-Toledo International
May 20, 2025
Upgrades: Buy
Price Target: $1,530 → $1,350
Current: $1,303.04
Upside: +3.60%
May 9, 2025
Maintains: Buy
Price Target: $95 → $70
Current: $59.27
Upside: +18.10%
May 8, 2025
Maintains: Neutral
Price Target: $57 → $45
Current: $36.52
Upside: +23.22%
May 2, 2025
Maintains: Buy
Price Target: $355 → $310
Current: $305.05
Upside: +1.62%
May 2, 2025
Maintains: Buy
Price Target: $355 → $310
Current: $307.90
Upside: +0.68%
May 1, 2025
Upgrades: Buy
Price Target: $145 → $115
Current: $91.14
Upside: +26.18%
Apr 7, 2025
Maintains: Overweight
Price Target: $122 → $99
Current: $89.67
Upside: +10.40%
Jan 17, 2025
Downgrades: Neutral
Price Target: $29 → $25
Current: $13.91
Upside: +79.73%
Jan 17, 2025
Downgrades: Neutral
Price Target: $250 → $185
Current: $170.13
Upside: +8.74%
Oct 18, 2024
Maintains: Neutral
Price Target: $7 → $9
Current: $9.32
Upside: -3.43%
Dec 7, 2023
Initiates: Neutral
Price Target: $35
Current: $22.39
Upside: +56.32%
Aug 10, 2023
Maintains: Neutral
Price Target: $225 → $200
Current: $91.00
Upside: +119.78%
Aug 8, 2023
Maintains: Neutral
Price Target: $14 → $11
Current: $3.23
Upside: +240.56%
Aug 4, 2023
Reiterates: Outperform
Price Target: $70
Current: $172.81
Upside: -59.49%
Feb 15, 2023
Reiterates: Underperform
Price Target: $7
Current: $15.58
Upside: -55.07%
Aug 25, 2022
Initiates: Neutral
Price Target: $345
Current: $333.14
Upside: +3.56%
Aug 25, 2022
Initiates: Neutral
Price Target: $260
Current: $185.91
Upside: +39.85%
Feb 4, 2022
Maintains: Equal-Weight
Price Target: $160 → $145
Current: $185.39
Upside: -21.79%
Feb 3, 2022
Maintains: Overweight
Price Target: $95 → $90
Current: $65.92
Upside: +36.53%
Dec 14, 2021
Maintains: Equal-Weight
Price Target: $62 → $64
Current: $47.50
Upside: +34.00%
Dec 14, 2021
Maintains: Overweight
Price Target: $330 → $340
Current: $279.78
Upside: +21.52%
Aug 10, 2021
Initiates: Overweight
Price Target: $24
Current: $24.12
Upside: -0.50%
Aug 14, 2019
Maintains: Hold
Price Target: $45 → $35
Current: $7.80
Upside: +348.72%